Novum Pharmaceutical Research Services, a subsidiary of Lambda Therapeutic Research, is a CRO with over 50 years of experience in the industry. Lambda & Novum deliver comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide. Our exemplary regulatory track record includes over 60 successful international inspections and audits by esteemed authorities such as the USFDA, EMEA, MHRA, EU member states, and other global bodies over the past five years.
We look forward to showcasing how our extensive experience and expertise in drug development can drive your project’s success. Take the opportunity to meet our team and discuss how we can customize our full-service capabilities to meet your specific needs.
Meet us at BIO-Europe Spring 2026
Novum Pharmaceutical Research Services and Lambda Therapeutic Research are excited to announce their participation in BIO-Europe Spring 2026, scheduled for 23-25 March 2026 in Lisboa (Lisbon), Portugal.
Schedule a meeting by filling out the form or reach out at to discuss how Lambda and Novum can support your drug development projects.